Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02382380 · ClinicalTrials.gov registry record · Phase 4
Evaluation of Gadoterate in Patients With Renal Dysfunction
A Phase 4 study, sponsored by Loyola University.
- Terminated
- Registry status
- Phase 4
- Development phase
- 46
- Enrollment target
NCT02382380 is a Phase 4 study that was terminated before completion, run by Loyola University. The registered enrollment target is 46 participants.
The verdict
NCT02382380, a Phase 4 study, was terminated before completion, sponsored by Loyola University.
- TERMINATED
- Registry status
- Phase 4
- Development phase
- 46 participants
- Enrollment target
Study Summary
This study is for individuals with decreased kidney function whose doctor has ordered Magnetic Resonance Imaging (MRI). Because kidney function is decreased, these patients usually do not receive the intravenous contrast material that can improve the accuracy of the MRI findings. The purpose of this study is to evaluate the safety and benefit of using a contrast material called Gadoterate in patients with decreased kidney function.
Interventions
- DRUG Gadoterate
- OTHER No Gadoterate
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 46 participants |
| Start Date | 2014-11-05 |
| Est. Completion | 2024-03-20 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02382380
The ClinicalTrials.gov registry entry for NCT02382380 describes a study currently listed as terminated, categorized as Phase 4. The registered enrollment target is 46 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Loyola University, which has 92 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Gadoterate is the first listed.
NCT02382380 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02382380 about?
NCT02382380 is a clinical study titled "Evaluation of Gadoterate in Patients With Renal Dysfunction". This study is for individuals with decreased kidney function whose doctor has ordered Magnetic Resonance Imaging (MRI). Because kidney function is decreased, these patients usually do not receive the intravenous contrast material that can improve the accuracy of the MRI findings. The purpose of this...
What is the current status of trial NCT02382380?
This trial is currently terminated. It is a Phase 4 study. The enrollment target is 46 participants. The study started on 2014-11-05. Estimated completion is 2024-03-20.
What interventions are being tested in trial NCT02382380?
The interventions under investigation include: Gadoterate (DRUG), No Gadoterate (OTHER).
Who is sponsoring clinical trial NCT02382380?
This trial is sponsored by Loyola University, which has 92 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.